A Retrospective Review on Feasibility and Safety of a New Pneumatic Compression Device for Femoral Arteriotomy Hemostasis

Overview

Journal Korean J Radiol

Specialty Radiology

Date 2012 Jan 17

PMID 22247637

Citations 1

Authors

Minho Kang

Sung Wook Shin

Affiliations

Soon will be listed here.

Abstract

Objective: To report our initial experience on the technical feasibility and safety for hemostasis of a new pneumatic compression device in patients undergoing femoral arteriotomy.

Materials And Methods: This study included 40 consecutive patients in whom hemostasis after transfemoral catheterization was readered by using a pneumatic compression device consisting of an inflatable bulb-containing main body and four pieces of supplementary tape. Medical records were retrospectively reviewed for outcomes and complications of hemostasis. Technical success was defined as achieving immediate hemostasis 10 minutes after applying the device over the arteriotomy sites, and clinical success was defined as the ability to ambulate after 4 hours of bed rest without any complications.

Results: Technical and clinical success was achieved in 38 (95%) and 37 (93%) patients, respectively. In two patients, hemostasis was achieved after conversion to manual compression. One patient required sand bag placement after removal of the device to control minimal oozing of blood. No patients had late complications.

Conclusion: The new pneumatic compression device provides effective and safe hemostasis after transfemoral catheterization in selected patient populations.

Citing Articles

Usefulness and safety of the "God's Hand" pneumatic compression device for hemostasis in femoral catheterization.

Kim S, Kwon J, Han Y, Kim J Diagn Interv Radiol. 2016; 23(1):49-54.

PMID: 27856404 PMC: 5214076. DOI: 10.5152/dir.2016.15451.

References

Kim Y, Yoon H, Ko G, Shin J, Sung K . Percutaneous transluminal angioplasty of suture-mediated closure device-related femoral artery stenosis or occlusive disease. Br J Radiol. 2008; 82(978):486-90. DOI: 10.1259/bjr/25029516. View

Bent C, Kyriakides C, Matson M . Femoral artery stenosis following percutaneous closure using a starclose closure device. Cardiovasc Intervent Radiol. 2008; 31(4):814-6. DOI: 10.1007/s00270-008-9341-5. View

Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M . Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004; 291(3):350-7. DOI: 10.1001/jama.291.3.350. View

Assali A, Sdringola S, Moustapha A, Ghani M, Salloum J, Schroth G . Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv. 2003; 58(1):1-5. DOI: 10.1002/ccd.10384. View

Chamberlin J, Lardi A, McKeever L, Wang M, Ramadurai G, Grunenwald P . Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv. 1999; 47(2):143-7; discussion 148. DOI: 10.1002/(SICI)1522-726X(199906)47:2<143::AID-CCD1>3.0.CO;2-M. View

Wada H, Usui M, Sakuragawa N . Hemostatic abnormalities and liver diseases. Semin Thromb Hemost. 2009; 34(8):772-8. DOI: 10.1055/s-0029-1145259. View

Dauerman H, Applegate R, Cohen D . Vascular closure devices: the second decade. J Am Coll Cardiol. 2007; 50(17):1617-26. DOI: 10.1016/j.jacc.2007.07.028. View

Jaspers L, Benit E . Immediate sheath removal after PCI using a Femostop is feasible and safe. Results of a registry. Acta Cardiol. 2004; 58(6):535-7. DOI: 10.2143/AC.58.6.2005318. View

Warren B, Warren S, Miller S . Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization. Catheter Cardiovasc Interv. 1999; 48(2):162-6. DOI: 10.1002/(sici)1522-726x(199910)48:2<162::aid-ccd8>3.0.co;2-2. View

10.

WALKER S, Cleary S, Higgins M . Comparison of the FemoStop device and manual pressure in reducing groin puncture site complications following coronary angioplasty and coronary stent placement. Int J Nurs Pract. 2002; 7(6):366-75. DOI: 10.1046/j.1440-172x.2001.00291.x. View

11.

Balzer J, Scheinert D, Diebold T, Haufe M, Vogl T, Biamino G . Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Catheter Cardiovasc Interv. 2001; 53(2):174-81. DOI: 10.1002/ccd.1144. View

12.

Madigan J, Ratnam L, Belli A . Arterial closure devices. A review. J Cardiovasc Surg (Torino). 2007; 48(5):607-24. View

13.

Jang J, Kim M, Gray B, Bacharach J, Olin J . Claudication secondary to Perclose use after percutaneous procedures. Catheter Cardiovasc Interv. 2006; 67(5):687-95. DOI: 10.1002/ccd.20646. View

14.

Juergens C, Leung D, Crozier J, Wong A, Robinson J, Lo S . Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004; 63(2):166-70. DOI: 10.1002/ccd.20161. View

15.

Dangas G, Mehran R, Kokolis S, Feldman D, Satler L, Pichard A . Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001; 38(3):638-41. DOI: 10.1016/s0735-1097(01)01449-8. View

16.

Kim H, Choo S, Roh H, Han H, Kim S, Lee J . Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures. Korean J Radiol. 2006; 7(1):35-40. PMC: 2667575. DOI: 10.3348/kjr.2006.7.1.35. View

17.

Brueck M, Bandorski D, Rauber K, Boening A . Percutaneous transluminal dilatation of inadvertent partial or complete occlusion of the femoral artery caused by Angio-Seal deployment for puncture site closure after cardiac catheterization. J Invasive Cardiol. 2010; 22(8):353-7. View

18.

Kunert M, Gremmler B, Schleiting H, Ulbricht L . Use of FemoStop system for arterial puncture site closure after coronary angioplasty. J Invasive Cardiol. 2004; 16(5):240-2. View

19.

Khaghany K, Al-Ali F, Spigelmoyer T, Pimentel R, Wharton K . Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol. 2005; 26(6):1420-4. PMC: 8149059. View

20.

Cooper C, Miller A . Infectious complications related to the use of the angio-seal hemostatic puncture closure device. Catheter Cardiovasc Interv. 1999; 48(3):301-3. DOI: 10.1002/(sici)1522-726x(199911)48:3<301::aid-ccd15>3.0.co;2-f. View